Cover Image
市場調查報告書

全球抗發炎性治療藥市場預測 (2017∼2027年):各適應症 (關節炎,呼吸疾病,多發性硬化症,乾癬,發炎性腸道疾病,其他),各類藥物 (皮質類固醇,抗發炎性生技藥品,NSAID,其他),地區收益預測

The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects By Indication (Arthritis, Respiratory, MS, Psoriasis, IBD, Other), Drug Class (Corticosteroids, Anti-Inflammatory Biologics, NSAIDs, Other) and Geography

出版商 Visiongain Ltd 商品編碼 534096
出版日期 內容資訊 英文 162 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球抗發炎性治療藥市場預測 (2017∼2027年):各適應症 (關節炎,呼吸疾病,多發性硬化症,乾癬,發炎性腸道疾病,其他),各類藥物 (皮質類固醇,抗發炎性生技藥品,NSAID,其他),地區收益預測 The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects By Indication (Arthritis, Respiratory, MS, Psoriasis, IBD, Other), Drug Class (Corticosteroids, Anti-Inflammatory Biologics, NSAIDs, Other) and Geography
出版日期: 2017年06月12日 內容資訊: 英文 162 Pages
簡介

全球抗發炎性治療市場2017年超越了750億美元。該市場預計至2027年大幅增加收益。預計自體免疫疾病的罹患率上升和高齡化使銷售額增加。

本報告提供全球抗發炎性治療市場相關調查,市場概要和各適應症,各類藥物,各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 調查概要

第2章 抗發炎性治療藥的簡介

  • 發炎的簡介
  • 發炎的種類
  • 抗發炎性治療藥的簡介
  • 抗發炎性治療藥的分類

第3章 全球各抗發炎性治療藥物市場

  • 全球市場概要
  • 全球抗發炎性治療藥市場
  • 2016∼2027年的預測
  • 推動市場因素和阻礙因素

第4章 各適應症市場

  • 市場概要
  • 市場預測
  • 市場佔有率
  • 關節炎
  • 乾癬
  • 呼吸疾病
  • 多發性硬化症
  • 發炎性腸道疾病
  • 治療開發平台分析

第5章 各類藥物市場

  • 市場概要
  • 市場預測
  • 市場佔有率
  • 皮質類固醇
  • 生技藥品
  • 非類固醇抗發炎性藥
  • 其他

第6章 主要國家市場

  • 各地區明細
  • 各地區預測
  • 美國
  • 歐洲5個國家
  • 日本
  • 巴西
  • 俄羅斯
  • 印度
  • 中國
  • 其他

第7章 主要企業

  • Johnson & Johnson (J&J)
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Roche
  • Amgen
  • Merck
  • AbbVie
  • Eli Lilly & Company
  • AstraZeneca

第8章 定性分析

  • SWOT分析
  • 波特五力分析

第9章 結論與建議

第10章 用語

目錄
Product Code: PHA0200

Anti-Inflammatory Therapeutics - our new study reveals trends, R&D progress, and predicted revenues

Where is the Anti-Inflammatory Therapeutics market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead

Our 162-page report provides 108 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Anti-Inflammatory Therapeutics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 5 Indications and 4 Drug Classes

Anti-Inflammatory Therapeutics Market Forecasts to 2027, By Indication

  • Arthritis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Inflammatory Bowel Diseases
  • Other

Anti-Inflammatory Therapeutics Market Forecasts to 2027, By Drug Class

  • Corticosteroids
  • Anti-Inflammatory Biologics
  • NSAIDs
  • Other Anti-Inflammatory Therapeutics

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 11 leading national markets:

  • The US
  • Canada
  • Germany
  • France
  • The UK
  • Italy
  • Spain
  • Japan
  • China
  • India
  • Russia
  • Brazil

The report also includes profiles and forecasts for some of the leading companies in the Anti-Inflammatory Therapeutics market, with a focus on the Anti-Inflammatory Therapeutics segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth

Overall world revenue for Anti-Inflammatory Therapeutics will surpass $75bn in 2017, our work calculates. We predict strong revenue growth through to 2027. The increasing prevalence of autoimmune disease, and increasing ageing population will increase sales to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Anti-Inflammatory Therapeutics Market report helps you

In summary, our 162-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the world Anti-Inflammatory Therapeutics market and 2 different segmentations, with forecasts for 5 Indications and 4 Drug Classes - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 11 of the leading national markets - US, Germany, UK, France, Italy, Spain, Japan, China, Brazil, Russia, India
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles and forecasts for 8 companies' anti-inflammatory segment revenues to 2027

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Anti-Inflammatory Therapeutics market and leading companies. You will find data, trends and predictions.

Get our report today The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication (Arthritis, Respiratory, MS, Psoriasis, IBD, Other), Drug Class (Corticosteroids, Anti-Inflammatory Biologics, NSAIDs, Other) and Geography. Avoid missing out - get our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. The Global Anti-Inflammatory Therapeutics Market Overview
  • 1.2. Global Anti-Inflammatory Therapeutics Market Segmentation
  • 1.3. Overview of Findings
  • 1.4. Structure of the Report
  • 1.5. Why you should Read this Report?
  • 1.6. How this Report Delivers
  • 1.7. Key Questions Answered by this Report
  • 1.8. Who is this Report for?
  • 1.9. Methodology
  • 1.10. Frequently Asked questions
  • 1.11. Associated Visiongain Reports
  • 1.12. About Visiongain

2. Introduction to Inflammation and Anti-Inflammatory Therapeutics

  • 2.1. An Introduction to Inflammation
    • 2.1.1. Causes of Inflammation
  • 2.2. Types of Inflammation
    • 2.2.1. Acute Inflammation
    • 2.2.2. Chronic Inflammation
  • 2.3. An Introduction to Anti-Inflammatory Therapeutics
  • 2.4. Classification of Anti-Inflammatory Therapeutics
    • 2.4.1. Anti-Inflammatory Therapeutics Segmentation by Indication
      • 2.4.1.1. Arthritis
      • 2.4.1.2. Respiratory Diseases
      • 2.4.1.3. Multiple Sclerosis
      • 2.4.1.4. Psoriasis
      • 2.4.1.5. Inflammatory Bowel Disease
    • 2.4.2. Anti-Inflammatory Therapeutics Segmentation, by Drug Class
      • 2.4.2.1. Anti-Inflammatory Biologics
      • 2.4.2.2. Non-Steroidal Anti-Inflammatory Drugs (NSAID'S)
      • 2.4.2.3. Corticosteroids

3. Anti-Inflammatory Therapeutics World Market 2016-2027

  • 3.1. Anti-Inflammatory Therapeutics: Global Market Overview, 2016
  • 3.2. The World Anti-Inflammatory Therapeutics Market
  • 3.3. World Anti-Inflammatory Therapeutics: Forecast to 2016-2027
  • 3.4. Anti-Inflammatory Therapeutics Market Drivers and Restraints

4. Anti-Inflammatory Therapeutics by Indication: World Market 2017-2027

  • 4.1. Anti-Inflammatory Therapeutics by Indication: Market Overview, 2016
  • 4.2. Anti-Inflammatory Therapeutics: Market Forecast 2017-2027
  • 4.3. Market Share of Anti-Inflammatory Therapeutics, by Indication
  • 4.4. Arthritis, 2016-2027
  • 4.5. Leading Drugs in Arthritis, 2016-2027
    • 4.5.1. Simponi/Simponi Aria (Johnson & Johnson)
    • 4.5.2. MabThera/Rituxan (Roche)
  • 4.6. Psoriasis, 2016-2027
  • 4.7. Leading Drugs: Psoriasis, 2016-2027
    • 4.7.1. Humira (AbbVie)
    • 4.7.2. Cosentyx (Novartis)
  • 4.8. Respiratory Diseases, 2016-2027
  • 4.9. Leading Drugs in Respiratory Diseases, 2016-2027
    • 4.9.1. Xolair (Genentech)
    • 4.9.2. Advair (GSK)
    • 4.9.3. Flovent (GSK)
    • 4.9.4. Symbicort(AstraZeneca)
  • 4.10. Multiple Sclerosis, 2016-2027
  • 4.11. Leading Drugs in Multiple Sclerosis, 2016-2027
    • 4.11.1. Plegridy (Biogen)
    • 4.11.2. Rebif (Merck)
  • 4.12. Inflammatory Bowel Diseases, 2016-2027
  • 4.13. Leading Drugs in Inflammatory Bowel Diseases, 2016-2027
    • 4.13.1. Entyvio (Takeda)
  • 4.14. Anti-Inflammatory Therapeutics Pipeline Analysis, 2016-2027

5. Anti-Inflammatory Therapeutics Market by Drug Class 2016-2026

  • 5.1. Global Anti-Inflammatory Therapeutics Market Overview, 2016
  • 5.2. Anti-Inflammatory Therapeutics by Drugs Class: Market Forecast 2016-2027
  • 5.3. Market share of Anti-Inflammatory Therapeutics, by Drug Class
  • 5.4. Corticosteroids, 2016-2027
  • 5.5. Anti-Inflammatory Biologics, 2016-2027
  • 5.6. Non-Steroidal Anti-Inflammatory Drugs, 2016-2027
  • 5.7. Other Drugs, 2016-2027

6. Leading National Markets, 2016-2027

  • 6.1. Geographical Breakdown of Global Anti-Inflammatory Therapeutics Market
  • 6.2. Global Anti-Inflammatory Therapeutics Market: Regional Forecast 2016-2027
    • 6.2.1. How Will Regional Market Shares Change to 2027?
  • 6.3. The US Anti-Inflammatory Therapeutics Market 2016-2027
    • 6.3.1. US Anti-Inflammatory Therapeutics Market Forecast 2016-2027
    • 6.3.2. US Anti-Inflammatory Therapeutics Market: Trends and Developments
  • 6.4. EU5 Anti-Inflammatory Therapeutics Market 2016-2027
    • 6.4.1. EU5 Anti-Inflammatory Therapeutics Market Forecast 2016-2027
      • 6.4.1.1. UK Anti-Inflammatory Therapeutics Market Forecast 2016-2027
      • 6.4.1.2. Germany Anti-Inflammatory Therapeutics Market Forecast 2016-2027
      • 6.4.1.3. France Anti-Inflammatory Therapeutics Market Forecast 2016-2027
      • 6.4.1.4. Italy Anti-Inflammatory Therapeutics Market Forecast 2016-2027
      • 6.4.1.5. Spain Anti-Inflammatory Therapeutics Market Forecast 2016-2027
  • 6.5. The Japanese Anti-Inflammatory Therapeutics Market, 2016-2027
  • 6.6. The Brazilian Anti-Inflammatory Therapeutics Market, 2016-2027
  • 6.7. The Russian Anti-Inflammatory Therapeutics Market, 2016-2027
  • 6.8. The Indian anti-inflammatory Therapeutics Market, 2016-2027
  • 6.9. The Chinese Anti-Inflammatory Therapeutics Market, 2016-2027
  • 6.10. The Rest of the World Anti-Inflammatory Therapeutics Market, 2016-2027

7. Leading Companies in the Anti-Inflammatory Therapeutics Market

  • 7.1. Johnson & Johnson (J&J)
    • 7.1.1. J&J: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.1.2. Johnson & Johnson Financial Overview
  • 7.2. GlaxoSmithKline
    • 7.2.1. GlaxoSmithKline: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.2.2. GlaxoSmithKline: Financial Overview
  • 7.3. Novartis
    • 7.3.1. Novartis: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.3.2. Novartis: Financial Overview
  • 7.4. Pfizer
    • 7.4.1. Pfizer: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.4.2. Pfizer: Financial Overview:
  • 7.5. Roche
    • 7.5.1. Roche: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.5.2. Roche: Financial Overview
  • 7.6. Amgen
    • 7.6.1. Amgen: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.6.2. Amgen: Financial Overview
  • 7.7. Merck
    • 7.7.1. Merck: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.7.2. Merck: Financial Overview
  • 7.8. AbbVie
    • 7.8.1. AbbVie: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.8.2. AbbVie: Financial Overview
  • 7.9. Eli Lilly & Company
    • 7.9.1. Eli Lilly & Company: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.9.2. Eli Lilly & Company: Financial Overview
  • 7.10. AstraZeneca
    • 7.10.1. AstraZeneca: Anti-Inflammatory Therapeutics Product Portfolio
    • 7.10.2. AstraZeneca: Financial Overview
  • 7.11. Other Companies of Interest in the Anti-Inflammatory Therapeutics Market

8. Qualitative Analysis

  • 8.1. SWOT Analysis
    • 8.1.1. Strengths
      • 8.1.1.1. Continuous Innovation and a Strong R&D Pipeline
      • 8.1.1.2. Increasing adoption rate of anti-inflammatory drugs
    • 8.1.2. Weakness
      • 8.1.2.1. Highly Competitive Market
      • 8.1.2.2. Patent Expiries
    • 8.1.3. Opportunities
      • 8.1.3.1. Increasing Prevalence of Diseases
      • 8.1.3.2. Development of Biosimilars for Existing Biologics
    • 8.1.4. Threats
      • 8.1.4.1. Side effects of Anti-Inflammatory Drugs
      • 8.1.4.2. Rising Market for Generics
  • 8.2. Porter Five Forces Analysis
    • 8.2.1. Competitive Rivalry
    • 8.2.2. Bargaining Power of Suppliers
    • 8.2.3. Bargaining Power of Customers
    • 8.2.4. Threat of New Entrants
    • 8.2.5. Threat of New Substitutes

9. Conclusions & Recommendations

  • 9.1. Anti-Inflammatory Therapeutics Market in 2016 and 2017
    • 9.1.1. Anti-Inflammatory Therapeutics Segments Revenue and Market Share in 2016, by Indication
    • 9.1.2. Anti-Inflammatory Therapeutics Segments Revenue and Market Share in 2016, by Drug Class
    • 9.1.3. Leading Anti-Inflammatory Therapeutics Companies
    • 9.1.4. Leading National Markets
  • 9.2. World Anti-Inflammatory Therapeutics Market Forecast 2016-2027
  • 9.3. The Future of Anti-Inflammatory Therapeutics Market

10. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 1.1: Projected Prevalence of Arthritis Related Conditions in the US, 2016-2027
  • Figure 1.2 Global Anti-Inflammatory Therapeutics Market Segmentation, 2017
  • Figure 3.1: Global Anti-Inflammatory Therapeutics Market, 2016-2027
  • Figure 3.2: Global Anti-Inflammatory Therapeutics Market by Segment: Drivers and Restraints, 2016-2027
  • Figure 4.1: Global Anti-Inflammatory Therapeutics Market by Segment: Revenue ($bn), AGR (%), 2017-2027
  • Figure 4.2: Global Anti-Inflammatory Therapeutics Market by Segment: Market Shares (%), 2016
  • Figure 4.3: Global Anti-Inflammatory Therapeutics Market by Segment: Market Shares (%), 2021
  • Figure 4.4: Global Anti-Inflammatory Therapeutics Market by Segment: Market Shares (%), 2021
  • Figure 4.5: Global Rheumatoid Arthritis Market by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 4.6: Global Osteoarthritis Market by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 4.7: Global Psoriasis Market by Segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 4.8: Global Asthma Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Figure 4.9: Global COPD Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Figure 4.10: Global Multiple Sclerosis Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Figure 4.11: Global Ulcerative Colitis Market: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Figure 4.12: Global Crohn's Disease Market: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Figure 5.1: Global Anti-Inflammatory Therapeutics Market by Drug Class: Revenue ($bn), AGR (%), CAGR (%),2016-2027
  • Figure 5.2: Global Anti-Inflammatory Therapeutic Market by Drug Class: Market Share (%), 2016
  • Figure 5.3: Global Anti-Inflammatory Therapeutic Market by Drug Class: Market Share (%), 2021
  • Figure 5.4: Global Anti-Inflammatory Therapeutic Market by Drug Class: Market Share (%), 2027
  • Figure 5.5: Global Corticosteroids Market: Revenue ($bn), AGR (%), CAGR (%), 2015-2016
  • Figure 5.6: Global Anti-Inflammatory Biologics: Revenue ($bn), AGR (%), 2016-2027
  • Figure 5.7: Global NSAIDs Market Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Figure 5.8: Global Other Anti-Inflammatory Drugs Market: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Figure 6.1: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), and Market Share (%), 2016
  • Figure 6.2: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), and Market Share (%), 2017
  • Figure 6.3: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 6.4: Global Anti-Inflammatory Therapeutics by Region: Market Shares (%), 2016
  • Figure 6.5: Global Anti-Inflammatory Therapeutics Market by Region: Market Shares (%), 2021
  • Figure 6.6: Global Anti-Inflammatory Therapeutics Market by Region: Market Shares (%), 2027
  • Figure 6.7: US Anti-Inflammatory Therapeutics Market: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
  • Figure 6.8: EU5 Anti-Inflammatory Therapeutics Market: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
  • Figure 6.9: EU5 Anti-Inflammatory Therapeutics Market: Market Shares (%) by National Market, 2016
  • Figure 6.10: EU5 Anti-Inflammatory Therapeutics Market: Market Shares (%) by National Market, 2021
  • Figure 6.11: EU5 Anti-Inflammatory Therapeutics Market: Market Shares (%) by National Market, 2027
  • Figure 6.12: UK Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
  • Figure 6.13: Germany Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
  • Figure 6.14: France Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
  • Figure 6.15: Italy Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
  • Figure 6.16: Spain Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 6.17: Japan Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 6.18: Brazil Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 6.19: Russian Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 6.20: Indian Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 6.21: Chinese Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 6.22: Rest of the World Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Figure 7.1: Johnson & Johnson: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Figure 7.2: GlaxoSmithKline: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
  • Figure 7.3: Novartis: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Figure 7.4: Pfizer: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Figure 7.5: Roche: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Figure 7.6: Amgen: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Figure 7.7: Merck: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Figure 7.8: AbbVie: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027

List of Tables

  • Table 1.1: Global Anti-Inflammatory Therapeutics Market Forecast by National Market Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 2.1: Feature of Acute and Chronic Inflammation
  • Table 3.1: Global Anti-Inflammatory Therapeutics, Revenue ($bn), 2016-2027
  • Table 4.1: Global Anti-Inflammatory Therapeutics Market by Indication: Revenue ($bn), and Market Share (%), 2016-2027
  • Table 4.2: Global Rheumatoid Arthritis Market by segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.3: Global Osteoarthritis Market by segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.4: Global Psoriasis Market by segment: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 4.5: Global Asthma Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Table 4.6: Global COPD Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Table 4.7: Global Multiple Sclerosis Market by segment: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Table 4.8: Global Ulcerative Colitis Market: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Table 4.9: Global Crohn's Disease Market: Revenue ($bn), AGR (%), and CAGR (%) 2016-2027
  • Table 4.10: Global Late-stage Pipeline Drugs, 2017
  • Table 5.1: Global Anti-Inflammatory Therapeutics Market by Drug Class: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 5.2: Global Corticosteroids Market: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 5.3: Global Anti-Inflammatory Biologics: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 5.4: Global NSAIDs Market: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 5.5: Global Other Anti-Inflammatory Drugs: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 6.1: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), and Market Share (%), 2016 and 2017
  • Table 6.2: Global Anti-Inflammatory Therapeutics Market by Region: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 6.3: US Anti-Inflammatory Therapeutics Market: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
  • Table 6.4: EU5 Anti-Inflammatory Therapeutics Market: Revenues ($bn), AGR (%), and CAGR (%), 2016-2027
  • Table 6.5: UK Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
  • Table 6.6: Germany Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
  • Table 6.7: France Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
  • Table 6.8: Italy Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%), and CAGR (%), 2016-2027
  • Table 6.9: Spain Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 6.10: Japan Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 6.11: Brazil Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 6.12: Russian Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 6.13: Indian Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 6.14 Chinese Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 6.15 Rest of the World Anti-Inflammatory Therapeutics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 7.1: Johnson & Johnson: Overview, 2017
  • Table 7.2: Johnson & Johnson: Anti-Inflammatory Therapeutics Product Portfolio
  • Table 7.3: Johnson & Johnson: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%) & CAGR (%), 2016-2026
  • Table 7.4: GlaxoSmithKline: Overview, 2017
  • Table 7.5: GlaxoSmithKline: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
  • Table 7.6: Novartis: Overview, 2017
  • Table 7.7: Novartis: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 7.8: Pfizer: Overview, 2017
  • Table 7.9: Pfizer: Anti-Inflammatory Therapeutics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
  • Table 7.10: Roche: Overview, 2017
  • Table 7.11: Roche: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
  • Table 7.12: Amgen: Overview, 2017
  • Table 7.13: Amgen: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
  • Table 7.14: Merck: Overview, 2017
  • Table 7.15: Merck: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
  • Table 7.16: AbbVie: Overview, 2017
  • Table 7.17: AbbVie: Anti-Inflammatory Therapeutics Revenue ($m), AGR (%), CAGR (%), 2016-2027
  • Table 7.18: Eli Lilly & Company: Overview, 2017
  • Table 7.19: AstraZeneca: Overview, 2017
  • Table 7.20 Other Companies of Interest in the Anti-Inflammatory Therapeutics Market
  • Table 8.1: SWOT Analysis of Anti-Inflammatory Therapeutics Market, 2016-2027

List of Companies:

  • Abbott Laboratories
  • AbbVie
  • Ablynx NV
  • Alcon
  • Alder Biopharmaceuticals
  • Amgen
  • Amylin
  • Anacor
  • Ardea Biosciences
  • Astellas Pharma
  • Avid Radiopharmaceuticals
  • Baxalta
  • Biocad
  • Biocon
  • Biogen
  • BioXpress Therapeutics
  • Boehringer Ingelheim
  • Bristol-Myers Squibb (BMS)
  • Can-Fite BioPharma
  • Celltrion Inc
  • Chiron
  • Chugai
  • Cipla
  • Coherus BioSciences
  • Covagen
  • Cubist
  • Daiichi Sankyo
  • Depuy
  • Dr. Reddy's Laboratories
  • Eli Lilly & Company
  • Epirus Biopharmaceuticals
  • Fremont
  • Fujifilm Corporation
  • Galapagos NV
  • Genentech
  • Gilead Sciences
  • GlaxoSmithKline
  • Hanmi Pharmaceutical Co
  • Hanwha Biologics
  • Hetero Healthcare
  • Hospira
  • Idenix
  • ImClone Systems
  • Immunex
  • Incyte Corporation
  • Intas Pharmaceuticals
  • Janssen
  • Johnson & Johnson
  • Kyowa Hakko Kirin Co
  • LG Life Sciences
  • MedImmune
  • Medivation
  • Merck
  • Mitsubishi Tanabe Pharma Corporation
  • Momenta Pharmaceuticals
  • MorphoSys
  • Mycenax Biotech
  • Mylan
  • Nichi-Iko Pharmaceutical Co
  • Novartis
  • Onyx
  • Pfizer
  • Pharmacyclics
  • Protalix Biotherapeutics
  • Roche
  • Roche Diagnostics
  • Samsung Bioepis Co
  • Samsung BioLogics
  • Sandoz
  • Sanofi
  • Shanghai Celgen Bio-Pharmaceutical Co
  • Shanghai CP Guojian Pharmaceutical Co
  • Sima Therapeutics
  • Simcere Pharmaceutical Group
  • Stiefel
  • Sun Pharmaceutical Industries
  • Takeda
  • Tempero
  • UCB
  • Vitaeris
  • Zydus Cadila

List of Organizations:

  • European Commission
  • European Medicines Agency
  • Food and Drug Administration (FDA)
  • Ministry of Health, Labor, and Welfare (MHLW)
  • National Center for Chronic Disease Prevention and Health Promotion
  • National Health Service (UK)
  • National Institutes of Health (NIH)
  • National Center for Chronic Disease Prevention and Health Promotion
  • Roszdravnadzor
  • Sistema Unico de Saude (SUS), Brazil
  • World Health Organization (WHO)
Back to Top